Skip to content

Where does hematopoiesis occur with age?

5 min read

The percentage of active hematopoietic tissue in the bone marrow decreases from 90% at birth to approximately 30-50% in old age. Understanding where does hematopoiesis occur with age reveals critical insights into the changes that affect senior health and immune function.

Quick Summary

During aging, the primary site of hematopoiesis remains the red bone marrow, but its location becomes more restricted, primarily in the axial skeleton, while bone marrow cellularity decreases and is replaced by fat. This change is accompanied by a functional decline in hematopoietic stem cells and shifts in the bone marrow microenvironment.

Key Points

  • Location Shifts: With age, active hematopoiesis concentrates in the axial skeleton (vertebrae, ribs, pelvis), leaving long bones to accumulate fatty tissue.

  • Functional Decline: The hematopoietic stem cell pool loses its regenerative capacity over time, despite an increase in stem cell numbers.

  • Myeloid Skewing: There is a shift in blood cell production towards myeloid lineages (innate immune cells) and away from lymphoid lineages (adaptive immune cells).

  • Niche Environment Aging: The bone marrow microenvironment changes with age, becoming more inflamed and fatty, which negatively impacts stem cell function.

  • Extramedullary Hematopoiesis: In certain pathological conditions, the liver and spleen can reactivate blood production, indicating compromised bone marrow function.

  • Increased Disease Risk: The age-related changes in hematopoiesis contribute to higher rates of anemia, immunodeficiency, and blood cancers in the elderly.

In This Article

The Body's Shifting Blood Factory

Throughout life, the site of hematopoiesis, or blood cell production, changes significantly. In the developing fetus, hematopoiesis occurs in multiple organs, including the yolk sac, liver, and spleen. After birth, the bone marrow takes over as the primary site. For young children, red marrow, which produces blood cells, is found in the long bones of the arms and legs, as well as the axial skeleton. As a person matures and ages, however, this pattern changes dramatically.

The Concentration of Red Marrow

In adults, red bone marrow becomes more concentrated in the central parts of the body, particularly the axial skeleton. This includes the skull, vertebrae (spine), ribs, sternum (breastbone), and the pelvic girdle (hips). The long bones of the limbs, once active sites in childhood, become largely inactive, and the red marrow is replaced by yellow bone marrow, which is primarily fat tissue. As we continue to age past 40, the proportion of red marrow in these remaining sites continues to decline, leading to a noticeable decrease in bone marrow cellularity. By age 70, the hematopoietic tissue may constitute only about 30% of the marrow space.

The Impact of an Aging Hematopoietic Stem Cell Pool

Beyond the physical location, the hematopoietic stem cells (HSCs) that drive blood production also undergo changes. With age, the number of HSCs can actually increase, yet their function diminishes. These aged HSCs become less efficient at regenerating and lose their balanced potential for differentiation. A key consequence is lineage skewing, a shift towards producing more myeloid cells (like monocytes and neutrophils) and fewer lymphoid cells (B- and T-cells). This imbalance contributes to the increased risk of myeloid malignancies and the weakened immune response, or immunosenescence, commonly seen in older adults.

The Influence of the Aging Microenvironment

The bone marrow is not just a cavity filled with stem cells; it is a complex, supportive microenvironment known as the hematopoietic niche. With age, this niche also changes. The aging bone marrow microenvironment sees an increase in inflammatory factors and signaling molecules. Additionally, there is an increase in adipocytes (fat cells) and a decrease in crucial supportive stromal cells. This aging niche environment sends altered signals to the resident HSCs, further promoting myeloid skewing and contributing to the functional decline observed. The interplay between the aged stem cells (intrinsic factors) and the aged niche (extrinsic factors) creates a feedback loop that accelerates hematopoietic aging.

The Phenomenon of Extramedullary Hematopoiesis

In a healthy adult, blood cell production is contained within the red bone marrow. However, in certain pathological conditions, the body can revert to a fetal-like state of blood production outside the marrow. This is known as extramedullary hematopoiesis and can occur in organs like the spleen and liver. This is not a normal part of the aging process but can be a compensatory mechanism in response to severe bone marrow failure, chronic anemia, or certain blood disorders. Its presence indicates that the bone marrow's capacity has been overwhelmed or compromised.

Comparison of Hematopoiesis: Young Adult vs. Aged Adult

Feature Young Adult Aged Adult
Primary Site Red bone marrow throughout the axial skeleton and ends of long bones. Red bone marrow primarily confined to the axial skeleton (skull, ribs, vertebrae, pelvis).
Marrow Composition High percentage of active red marrow, less yellow (fatty) marrow. Significantly reduced red marrow cellularity, with higher percentage of yellow, fatty marrow.
HSC Function High regenerative and self-renewal potential, producing a balanced ratio of blood cells. Diminished regenerative capacity, with impaired function despite potentially higher numbers.
Lineage Differentiation Balanced production of both myeloid and lymphoid lineages. Skewed towards myeloid cell production, with decreased lymphoid output.
Niche Environment A supportive microenvironment with optimal cytokine and growth factor signaling. An aged niche with increased inflammation and fat deposition, sending altered signals to HSCs.
Risk of Malignancy Lower risk of hematopoietic malignancies. Higher risk of clonal hematopoiesis and blood cancers.

Why These Changes Matter

The age-related decline in hematopoietic function has profound implications for senior health. It underlies the increased prevalence of conditions like anemia and immunodeficiency in older populations. Anemia can cause weakness and fatigue, while immunodeficiency leaves seniors more vulnerable to infections. Furthermore, the molecular and cellular changes, such as accumulation of DNA damage and epigenetic alterations in HSCs, contribute to a higher risk of developing hematological malignancies. A deeper understanding of these changes is key to developing new therapeutic strategies and better care for the elderly.

To learn more about the complex factors driving age-related changes, see the detailed review by the National Institutes of Health. Hematopoietic aging: Cellular, molecular, and related mechanisms.

In conclusion, hematopoiesis with age becomes a more localized and less efficient process. While it primarily remains in the axial skeleton, the functional output is compromised, with a myeloid bias, reduced regenerative potential, and increased risk of disease due to changes in both the stem cells and their surrounding bone marrow environment. This is a complex aspect of aging that directly impacts overall health and resilience. The continuous research in this field offers hope for potential interventions to mitigate these age-related declines and support healthier aging.

Summary of Key Factors Affecting Hematopoiesis in the Elderly

  1. Declining Bone Marrow Cellularity: As we age, active red bone marrow is increasingly replaced by fatty yellow marrow, reducing the space for blood cell production.
  2. Location Shift: The site of blood cell production moves from encompassing most bones in childhood to being concentrated in the central skeleton in older adults.
  3. HSC Functional Decline: Individual hematopoietic stem cells lose their regenerative potential and balanced differentiation capacity over time, even as their overall numbers may increase.
  4. Lineage Skewing: The production of blood cells shifts towards myeloid lineages (e.g., neutrophils, monocytes) at the expense of lymphoid lineages (B- and T-cells), impairing immune function.
  5. Niche Aging: The bone marrow microenvironment, or niche, becomes inflamed and accumulates fat, sending altered signals that negatively impact HSC function.
  6. Genetic and Epigenetic Changes: Accumulated DNA damage and epigenetic modifications in HSCs are major molecular drivers of age-related hematopoietic decline and increase cancer risk.
  7. Compensatory Extramedullary Hematopoiesis: In cases of severe stress or disease, blood production can abnormally resume in organs like the liver and spleen to compensate for bone marrow failure.

Frequently Asked Questions

With age, hematopoiesis primarily occurs in the red bone marrow of the axial skeleton, which includes the ribs, sternum, vertebrae, skull, and pelvis. The fatty yellow marrow replaces red marrow in many other bones over time.

Red bone marrow is the active site of blood cell production (hematopoiesis), while yellow bone marrow is primarily composed of fat cells and is mostly inactive. With age, the proportion of red marrow decreases while yellow marrow increases.

Myeloid skewing is an age-related phenomenon where hematopoietic stem cells disproportionately produce myeloid lineage cells (e.g., neutrophils, monocytes) at the expense of lymphoid lineage cells (B- and T-cells). This leads to a weaker adaptive immune system.

Yes, in abnormal circumstances, older adults may experience extramedullary hematopoiesis, where blood cell production occurs outside the bone marrow in organs like the liver or spleen. This is typically a compensatory response to severe bone marrow problems.

Yes, the aging bone marrow microenvironment, or niche, undergoes changes such as increased inflammation and fat deposition. This sends altered signals to hematopoietic stem cells, contributing to their functional decline and skewed differentiation.

The shift away from lymphoid cell production with age, combined with other cellular changes, results in immunosenescence. This is a decline in immune function, making older adults more susceptible to infections and reducing the effectiveness of vaccinations.

Clonal hematopoiesis is the expansion of certain hematopoietic stem cell clones that carry specific genetic mutations, and it becomes more common with age. While it doesn't always lead to disease, it increases the risk of developing hematological malignancies and is a hallmark of the aging hematopoietic system.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.